{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:38:53Z","timestamp":1791920333735,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.nbd.2023.106157","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T16:03:39Z","timestamp":1684425819000},"page":"106157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["A mitochondrial-targeted antioxidant (MitoQ) improves motor coordination and reduces Purkinje cell death in a mouse model of ARSACS"],"prefix":"10.1016","volume":"183","author":[{"given":"Brenda Toscano","family":"M\u00e1rquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsz Chui Sophia","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Charron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Anne","family":"McKinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanna J.","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2023.106157_bb0005","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1113\/JP275902","article-title":"Altered synaptic and intrinsic properties of cerebellar Purkinje cells in a mouse model of ARSACS","volume":"596","author":"Ady","year":"2018","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2023.106157_bb0010","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/med.21712","article-title":"Mitochondria and lipid peroxidation in the mechanism of neurodegeneration: finding ways for prevention","volume":"41","author":"Angelova","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.nbd.2023.106157_bb0015","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1093\/hmg\/ddr197","article-title":"FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3","volume":"20","author":"Araujo","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2023.106157_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038026","article-title":"Human SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson\u2019s disease","volume":"7","author":"Belluzzi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2023.106157_bb0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1017\/S0317167100024793","article-title":"Autosomal recessive spastic ataxia of Charlevoix-Saguenay","volume":"5","author":"Bouchard","year":"1978","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2023.106157_bb0030","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.neuron.2009.12.011","article-title":"Sodium entry during action potentials of mammalian neurons: incomplete inactivation and reduced metabolic efficiency in fast-spiking neurons","volume":"64","author":"Carter","year":"2009","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2023.106157_bb0035","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1093\/hmg\/ddp326","article-title":"Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases","volume":"18","author":"Chen","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2023.106157_bb0040","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuroscience.2020.06.008","article-title":"Losing the beat: contribution of Purkinje cell firing dysfunction to disease, and its reversal","volume":"462","author":"Cook","year":"2021","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2023.106157_bb0045","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1007\/s00415-015-7911-4","article-title":"Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay","volume":"262","author":"Criscuolo","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2023.106157_bb0050","first-page":"3130","article-title":"Altered organization of the intermediate filament cytoskeleton and relocalization of proteostasis modulators in cells lacking the ataxia protein sacsin","volume":"26","author":"Duncan","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2023.106157_bb0055","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/72769","article-title":"ARSACS, a spastic ataxia common in northeastern Quebec, is caused by mutations in a new gene encoding an 11.5-kb ORF","volume":"24","author":"Engert","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2023.106157_bb0060","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1523\/JNEUROSCI.0482-06.2006","article-title":"Reduction in mitochondrial superoxide dismutase modulates Alzheimer\u2019s disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice","volume":"26","author":"Esposito","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2023.106157_bb0065","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jns.2012.05.030","article-title":"Mitochondria, oxidative stress and neurodegeneration","volume":"322","author":"Federico","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2023.106157_bb0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.freeradbiomed.2013.05.027","article-title":"SOD2 in mitochondrial dysfunction and neurodegeneration","volume":"62","author":"Flynn","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2023.106157_bb0075","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1096\/fj.201801556R","article-title":"Sacsin, mutated in the ataxia ARSACS, regulates intermediate filament assembly and dynamics","volume":"33","author":"Gentil","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2023.106157_bb0080","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.1113166109","article-title":"Mitochondrial dysfunction and Purkinje cell loss in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)","volume":"109","author":"Girard","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2023.106157_bb0085","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fnagi.2015.00196","article-title":"Neurostereology protocol for unbiased quantification of neuronal injury and neurodegeneration","volume":"7","author":"Golub","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.nbd.2023.106157_bb0090","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1096\/fj.03-0240fje","article-title":"Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants","volume":"17","author":"Jauslin","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2023.106157_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/ENEURO.0094-15.2015","article-title":"Rapid onset of motor deficits in a mouse model of spinocerebellar ataxia type 6 precedes late cerebellar degeneration","volume":"2","author":"Jayabal","year":"2015","journal-title":"eNeuro."},{"key":"10.1016\/j.nbd.2023.106157_bb0100","doi-asserted-by":"crossref","first-page":"29489","DOI":"10.1038\/srep29489","article-title":"4-aminopyridine reverses ataxia and cerebellar firing deficiency in a mouse model of spinocerebellar ataxia type 6","volume":"6","author":"Jayabal","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2023.106157_bb0105","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/modpathol.2016.176","article-title":"A novel quantitative immunohistochemistry method for precise protein measurements directly in formalin-fixed, paraffin-embedded specimens: analytical performance measuring HER2","volume":"30","author":"Jensen","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.nbd.2023.106157_bb0110","first-page":"11","article-title":"Neuroprotective benefits of exercise and MitoQ on memory function, mitochondrial dynamics, oxidative stress, and neuroinflammation in D-Galactose-Induced aging rats","author":"Jeong","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.nbd.2023.106157_bb0115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1113\/jphysiol.2011.221846","article-title":"Lobule-specific membrane excitability of cerebellar Purkinje cells","volume":"590","author":"Kim","year":"2012","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2023.106157_bb0120","doi-asserted-by":"crossref","first-page":"20407","DOI":"10.1074\/jbc.M111.232884","article-title":"Structural basis of defects in the sacsin HEPN domain responsible for autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)","volume":"286","author":"Kozlov","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2023.106157_bb0125","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/hmg\/ddu491","article-title":"Sacs knockout mice present pathophysiological defects underlying autosomal recessive spastic ataxia of Charlevoix-Saguenay","volume":"24","author":"Lariviere","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2023.106157_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13041-019-0438-3","article-title":"Sacs R272C missense homozygous mice develop an ataxia phenotype","volume":"12","author":"Lariviere","year":"2019","journal-title":"Mol. Brain."},{"key":"10.1016\/j.nbd.2023.106157_bb0135","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1471-4159.2004.02455.x","article-title":"Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice","volume":"89","author":"Li","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2023.106157_bb0140","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.bbadis.2013.09.005","article-title":"MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis","volume":"1832","author":"Mao","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2023.106157_bb0145","doi-asserted-by":"crossref","first-page":"15703","DOI":"10.1523\/JNEUROSCI.0552-11.2011","article-title":"The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer\u2019s disease","volume":"31","author":"McManus","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2023.106157_bb0150","doi-asserted-by":"crossref","first-page":"12832","DOI":"10.1074\/jbc.RA118.003939","article-title":"Structures of ubiquitin-like (Ubl) and Hsp90-like domains of sacsin provide insight into pathological mutations","volume":"293","author":"Menade","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2023.106157_bb0155","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.freeradbiomed.2014.02.019","article-title":"Neuroprotective effects of the mitochondria-targeted antioxidant MitoQ in a model of inherited amyotrophic lateral sclerosis","volume":"70","author":"Miquel","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2023.106157_bb0160","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nbd.2006.02.014","article-title":"Conditional knockout of Mn superoxide dismutase in postnatal motor neurons reveals resistance to mitochondrial generated superoxide radicals","volume":"23","author":"Misawa","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2023.106157_bb0165","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbadis.2009.10.007","article-title":"Mitochondria: a therapeutic target in neurodegeneration","volume":"1802","author":"Moreira","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2023.106157_bb0170","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.freeradbiomed.2014.03.003","article-title":"The mitochondria-targeted antioxidant MitoQ extends lifespan and improves healthspan of a transgenic Caenorhabditis elegans model of Alzheimer disease","volume":"71","author":"Ng","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2023.106157_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102113","article-title":"The mitochondria-targeted antioxidant MitoQ attenuated PM2.5-induced vascular fibrosis via regulating mitophagy","volume":"46","author":"Ning","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.nbd.2023.106157_bb0180","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.freeradbiomed.2019.11.021","article-title":"The interplay between redox signalling and proteostasis in neurodegeneration: in vivo effects of a mitochondria-targeted antioxidant in Huntington\u2019s disease mice","volume":"146","author":"Pinho","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"Suppl. 3","key":"10.1016\/j.nbd.2023.106157_bb0185","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.3233\/JAD-132738","article-title":"Apoptosis and oxidative stress in neurodegenerative diseases","volume":"42","author":"Radi","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2023.106157_bb0190","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1089\/15230860260196254","article-title":"Elevated oxidative stress in patients with ataxia telangiectasia","volume":"4","author":"Reichenbach","year":"2002","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.nbd.2023.106157_bb0195","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.neuroscience.2004.08.050","article-title":"Design-based stereology in neuroscience","volume":"130","author":"Schmitz","year":"2005","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2023.106157_bb0200","first-page":"10","article-title":"Treating neurodegenerative disease with antioxidants: efficacy of the bioactive phenol resveratrol and mitochondrial-targeted MitoQ and SkQ","author":"Shinn","year":"2021","journal-title":"Antioxidants (Basel)."},{"key":"10.1016\/j.nbd.2023.106157_bb0205","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2010.05627.x","article-title":"Animal and human studies with the mitochondria-targeted antioxidant MitoQ","volume":"1201","author":"Smith","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2023.106157_bb0210","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1073\/pnas.0931245100","article-title":"Delivery of bioactive molecules to mitochondria in vivo","volume":"100","author":"Smith","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2023.106157_bb0215","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/mds.23148","article-title":"A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson\u2019s disease","volume":"25","author":"Snow","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2023.106157_bb0220","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbadis.2012.07.009","article-title":"The mitochondria-targeted anti-oxidant MitoQ reduces aspects of mitochondrial fission in the 6-OHDA cell model of Parkinson\u2019s disease","volume":"1832","author":"Solesio","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2023.106157_bb0225","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.freeradbiomed.2016.07.005","article-title":"Mitochondrial impairments contribute to spinocerebellar ataxia type 1 progression and can be ameliorated by the mitochondria-targeted antioxidant MitoQ","volume":"97","author":"Stucki","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2023.106157_bb0230","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbadis.2009.09.013","article-title":"Abnormal mitochondrial dynamics and neurodegenerative diseases","volume":"1802","author":"Su","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2023.106157_bb0235","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1750-1172-8-41","article-title":"Autosomal recessive spastic ataxia of Charlevoix Saguenay (ARSACS): expanding the genetic, clinical and imaging spectrum","volume":"8","author":"Synofzik","year":"2013","journal-title":"Orphan. J. Rare Dis."},{"key":"10.1016\/j.nbd.2023.106157_bb0240","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0005-2728(98)00167-4","article-title":"Apoptosis in neurodegenerative diseases: the role of mitochondria","volume":"1410","author":"Tatton","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2023.106157_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.707857","article-title":"Molecular identity and location influence Purkinje cell vulnerability in autosomal-recessive spastic Ataxia of Charlevoix-Saguenay mice","volume":"15","author":"Toscano Marquez","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2023.106157_bb0250","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nn1648","article-title":"Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia","volume":"9","author":"Walter","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2023.106157_bb0255","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.neuropharm.2011.07.008","article-title":"Protective efficacy of mitochondrial targeted antioxidant MitoQ against dichlorvos induced oxidative stress and cell death in rat brain","volume":"61","author":"Wani","year":"2011","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.nbd.2023.106157_bb0260","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/hmg\/ddw045","article-title":"Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington\u2019s disease","volume":"25","author":"Yin","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2023.106157_bb0265","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02536","article-title":"Cerebellar modules operate at different frequencies","volume":"3","author":"Zhou","year":"2014","journal-title":"Elife."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123001717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123001717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T11:35:20Z","timestamp":1716377720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996123001717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":53,"alternative-id":["S0969996123001717"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106157","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A mitochondrial-targeted antioxidant (MitoQ) improves motor coordination and reduces Purkinje cell death in a mouse model of ARSACS","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106157"}}